The laboratory will enhance the international visibility of UAE and UAEU in the fields of medical genomics and metabolomics research by:
- Being the leading source of research into the causes and pathogenesis of genetic diseases in the UAE
- Establishing collaborations with leading local, international and regional genomics research and services institutions
- Translating inventions into patents and possibly marketable products to prompt the establishment of innovative entrepreneurial initiatives and start-up biotechnology companies in UAE
- Develop and provide competitive and innovative research and diagnostic solutions to healthcare, biotechnology and pharmaceutical sectors
- Seeking and developing novel approaches to prevent, diagnose and treat genetic disorders
- Identifying the genetic components of common multifactorial disorders such as cancer, obesity, diabetes and cardiovascular disorders in the UAE.
- Define relevant and actionable pharmacogenomics biomarkers relevant to medications prescribed to Emirati patients.
- Studying the metabolome of inborn errors of metabolism and other metabolic disorders